Notes

Architectural and also PK-guided detection of indole-based non-acidic autotaxin (ATX) inhibitors displaying loaded with vivo anti-fibrosis effectiveness within mouse style.
Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the coccidiostat STENOROL ® containing halofuginone hydrobromide (halofuginone HBr) as active substance. The FEEDAP Panel was not able to conclude on the safety of STENOROL ® for chickens and turkeys for fattening at the highest proposed use level. No incompatibilities or interactions with feedingstuffs, carriers, other approved additives or medicinal drugs are expected. Halofuginone HBr does not have antimicrobial activity at the highest dose proposed; it is not expected to exert adverse effects on chicken gut microbiota or select for resistance and cross-resistance with other antimicrobials. The Panel cannot conclude on the genotoxic potential of halofuginone HBr since an appropriate in vivo follow-up to exclude the mutagenic effect of the compound was not available. selleck chemicals Therefore, the FEEDAP Panel cannot conclude on the safety of halofuginone HBr for the consumer. The additive is toxic by inhalation, dermal and ocular routes and is very irritant to both the eye and the skin. It is considered also a skin sensitiser. Inhalation exposure is considered a risk to persons handling the additive. Since the lack of genotoxic potential of halofuginone HBr has not been adequately demonstrated, it should be considered as an additional potential concern to users handling the additive. Due to limitations in some of the ecotoxicological studies, no conclusions can be drawn on the safety of the additive for the environment. The FEEDAP Panel is not in the position to conclude on the efficacy of STENOROL ® in chickens for fattening and in turkeys for fattening.The Institute of Paediatric Virology, founded on October 2019 on the island of Euboea in Greece, introduces medical students, paediatric and neonatal trainees, postgraduate students, virologists, paediatric and allied health professionals to the bold, new, scientific field of paediatric virology. The institute is committed to medical education and is the sequel of the Paediatric Virology Study Group (PVSG), which was formed in 2007 in the United Kingdom by a group of young paediatric trainees and junior researchers. The main mission of the institute is to provide an educational e-platform on neonatal and paediatric viral infections, to facilitate scientific discussion between virologists and paediatric health professionals and to develop an international network aiming to the promotion of children's health by the prevention and treatment of viral infectious diseases. The foundation of the institute is dedicated to three children from a small fishing village at the south of the island of Euboea in Greece, who survived the 1918 Spanish flu pandemic.The 'George N. Papanicolaou Medal' is a brass medal commissioned by the Academy of Athens on the occasion of the 100th anniversary of the birth of Dr George N. Papanicolaou in 1983. It was created by Professor Theodoros Papagiannis, Professor Emeritus of Sculpture at the Athens School of Fine Arts in Athens, Greece; the medal presents Dr George N. Papanicolaou with his microscope. According to Professor Papagiannis, the medal was requested by Professor Nikolaos Louros, Emeritus Professor of Obstetrics and Gynecology at the University of Athens School of Medicine and it was created according to the ancient Greek style. The medal was given to all honored participants of the special ceremony organized by the Academy of Athens in May 13th, 1983, in the context of the 100 years from the birth of Dr George N. Papanicolaou. The ceremony was performed at the Central Hall of the Academy of Athens in Athens under the auspices of the President of the Hellenic Democracy Constantinos Caramanlis. A copy of this medal is being exhibited at the 'Museum of Contemporary Sculpture Theodoros Papagiannis' in Elliniko at the Municipality of Katsanochoria close to Ioannina (Greece), as well as at the newly founded Institute of Paediatric Virology based on the island of Euboea, birth place of Dr George N. Papanicolaou.Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus, which causes coronavirus disease 2019 (COVID-19) and affects children less frequently than adults. According to Professor Vana Papaevangelou, Professor of Paediatrics at the University of Athens School of Medicine, children comprise only 2-6% of COVID-19 cases, worldwide, and they are not considered as super-spreaders of this infection. SARS-CoV-2 is transmitted through droplets, fomites, aerosol and fecal-oral route, while there is no strong evidence as yet, supporting transplacental transmission. Professor Papaevangelou highlights the epidemiological differences between seasonal influenza and COVID-19 and accepts that school closure had no direct impact since children are not the main transmitters of SARS-CoV-2. On the other hand, social distancing clearly limited the transmission of SARS-CoV-2, while quarantine seemed necessary during the first wave of this pandemic. She refers to antivirals, as well as other therapeutic agents able to diminish the immune response producing multisystem inflammatory syndrome, which is associated with increased mortality, and she notes that these agents were rarely used in children with COVID-19, while in most cases supportive treatment sufficed. She finishes with the ongoing scientific efforts for the development of an effective and safe vaccine against SARS-CoV-2 indicating that so far the most promising vaccine developments include vaccines that use viral vectors.Epilepsy in childhood is one of the most common neurological disorders encountered in paediatric clinical practice. The current treatment of paediatric epilepsy aims to improve health outcomes, as well as to manage the educational, social and psychological issues that are involved in the quality of life of paediatric patients and their parents. In this direction, in several countries, a specialized, comprehensive, multidisciplinary service has been developed, including paediatric epilepsy nursing, which constitute a key component of this service. According to Mrs. Jennifer O'Brien, one of the pioneering paediatric epilepsy nursing specialists in the UK with a significant contribution in the care of children with epilepsy in Merseyside, the mission of paediatric epilepsy nursing is to enable children with epilepsy and their families to live as normal a life as possible, to ensure that all those who care for the child are well-educated regarding the child's epilepsy and to promote the child's safety and integration into society.
Website: https://www.selleckchem.com/products/r428.html